| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |